Nonclinical Safety Strategy for Combinations of Biopharmaceuticals or a Biopharmaceutical with a Small Molecular Weight Compound
M Dempster, HG Haggerty - Translational Medicine, 2021 - taylorfrancis.com
Combination drug therapy is an important tool to treat complex diseases. However, with
enhanced efficacy comes the risk for greater toxicity. This chapter discusses the nonclinical …
enhanced efficacy comes the risk for greater toxicity. This chapter discusses the nonclinical …
Nonclinical Safety Strategy for Combinations of Biopharmaceuticals or a Biopharmaceutical with a Small Molecular Weight Compound
M Dempster, HG Haggerty - Translational Medicine: Optimizing …, 2021 - books.google.com
Combination drug therapy continues to be an important tool in a pharmaceutical company's
arsenal with which to treat complex diseases, such as cancer viral and autoimmune …
arsenal with which to treat complex diseases, such as cancer viral and autoimmune …